Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-02-012501
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
9
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405 a2074309z10-k405.txt 10-K405 340601
3 EXHIBIT 10.61 a2074309zex-10_61.txt EX-10.61 130769
4 EXHIBIT 10.62 a2074309zex-10_62.txt EX-10.62 3737
5 EXHIBIT 10.63 a2074309zex-10_63.txt EX-10.63 71298
6 EXHIBIT 10.64 a2074309zex-10_64.txt EX-10.64 18259
7 EXHIBIT 10.65 a2074309zex-10_65.txt EX-10.65 44634
8 EXHIBIT 10.66 a2074309zex-10_66.txt EX-10.66 5053
9 EXHIBIT 23.1 a2074309zex-23_1.txt EX-23.1 648
10 EXHIBIT 23.2 a2074309zex-23_2.txt EX-23.2 1114
  Complete submission text file 0000912057-02-012501.txt   618535
Mailing Address 24 EMILY ST CAMBRIDGE MA 02139
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Filer) CIK: 0000912183 (see all company filings)

EIN.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21379 | Film No.: 02593183
SIC: 2834 Pharmaceutical Preparations